ArticleTrials2021

Effects of immunoglobulin plus prednisolone in reducing coronary artery lesions in patients with Kawasaki disease: study protocol for a phase III multicenter, open-label, blinded-endpoints randomized controlled trial.

Si-Yuan Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.